"


Journal

Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780

Informations de publication

Date de publication:
06 2019
Historique:
entrez: 14 3 2019
pubmed: 14 3 2019
medline: 22 3 2019
Statut: ppublish

Résumé

To achieve Sustainable Development Goals and Universal Health Coverage, programmatic data are essential. The Every Newborn Action Plan, agreed by all United Nations member states and >80 development partners, includes an ambitious Measurement Improvement Roadmap. Quality of care at birth is prioritised by both Every Newborn and Ending Preventable Maternal Mortality strategies, hence metrics need to advance from health service contact alone, to content of care. As facility births increase, monitoring using routine facility data in DHIS2 has potential, yet validation research has mainly focussed on maternal recall surveys. The EN-BIRTH is an observational study including >20 000 facility births in three countries (Tanzania, Bangladesh and Nepal) to validate selected indicators. Direct clinical observation will be compared with facility register data and a pre-discharge maternal recall survey for indicators including: uterotonic administration, immediate newborn care, neonatal resuscitation and Kangaroo mother care. Indicators including neonatal infection management and antenatal corticosteroid administration, which cannot be easily observed, will be validated using inpatient records. Trained clinical observers in Labour/Delivery ward, Operation theatre, and Kangaroo mother care ward/areas will collect data using a tablet-based customised data capturing application. Sensitivity will be calculated for numerators of all indicators and specificity for those numerators with adequate information. Other objectives include comparison of denominator options (ie, true target population or surrogates) and quality of care analyses, especially regarding intervention timing. Barriers and enablers to routine recording and data usage will be assessed by data flow assessments, quantitative and qualitative analyses. To our knowledge, this is the first large, multi-country study validating facility-based routine data compared to direct observation for maternal and newborn care, designed to provide evidence to inform selection of a core list of indicators recommended for inclusion in national DHIS2. Availability and use of such data are fundamental to drive progress towards ending the annual 5.5 million preventable stillbirths, maternal and newborn deaths.

Sections du résumé

BACKGROUND
To achieve Sustainable Development Goals and Universal Health Coverage, programmatic data are essential. The Every Newborn Action Plan, agreed by all United Nations member states and >80 development partners, includes an ambitious Measurement Improvement Roadmap. Quality of care at birth is prioritised by both Every Newborn and Ending Preventable Maternal Mortality strategies, hence metrics need to advance from health service contact alone, to content of care. As facility births increase, monitoring using routine facility data in DHIS2 has potential, yet validation research has mainly focussed on maternal recall surveys. The
METHODS
EN-BIRTH is an observational study including >20 000 facility births in three countries (Tanzania, Bangladesh and Nepal) to validate selected indicators. Direct clinical observation will be compared with facility register data and a pre-discharge maternal recall survey for indicators including: uterotonic administration, immediate newborn care, neonatal resuscitation and Kangaroo mother care. Indicators including neonatal infection management and antenatal corticosteroid administration, which cannot be easily observed, will be validated using inpatient records. Trained clinical observers in Labour/Delivery ward, Operation theatre, and Kangaroo mother care ward/areas will collect data using a tablet-based customised data capturing application. Sensitivity will be calculated for numerators of all indicators and specificity for those numerators with adequate information. Other objectives include comparison of denominator options (ie, true target population or surrogates) and quality of care analyses, especially regarding intervention timing. Barriers and enablers to routine recording and data usage will be assessed by data flow assessments, quantitative and qualitative analyses.
CONCLUSIONS
To our knowledge, this is the first large, multi-country study validating facility-based routine data compared to direct observation for maternal and newborn care, designed to provide evidence to inform selection of a core list of indicators recommended for inclusion in national DHIS2. Availability and use of such data are fundamental to drive progress towards ending the annual 5.5 million preventable stillbirths, maternal and newborn deaths.

Identifiants

pubmed: 30863542
doi: 10.7189/jogh.09.010902
pii: jogh-09-010902
pmc: PMC6406050
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

010902

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Déclaration de conflit d'intérêts

Competing interests: The authors completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available upon request from the corresponding author), and declare no conflicts of interest.

Références

Radiol Manage. 1996 May-Jun;18(3):45-9
pubmed: 10158370
Lancet. 2005 Mar 5-11;365(9462):891-900
pubmed: 15752534
Health Policy Plan. 2009 May;24(3):217-28
pubmed: 19304786
Trop Doct. 2009 Jul;39(3):145-9
pubmed: 19535748
Int J Gynaecol Obstet. 2009 Oct;107 Suppl 1:S47-62, S63-4
pubmed: 19815203
BMC Public Health. 2011 Apr 13;11 Suppl 3:S12
pubmed: 21501429
Midwifery. 2012 Jun;28(3):329-39
pubmed: 21684639
Lancet. 2012 Jun 9;379(9832):2162-72
pubmed: 22682464
BMC Pediatr. 2012 Oct 05;12:159
pubmed: 23039709
BMJ Open. 2013 Apr 24;3(4):null
pubmed: 23619087
PLoS Med. 2013;10(5):e1001421
pubmed: 23667338
PLoS Med. 2013;10(5):e1001423
pubmed: 23667340
PLoS One. 2013 May 07;8(5):e60694
pubmed: 23667427
PLoS One. 2013 May 07;8(5):e60762
pubmed: 23667429
Pediatr Res. 2013 Dec;74 Suppl 1:1-3
pubmed: 24240732
J Clin Epidemiol. 2014 Mar;67(3):267-77
pubmed: 24275499
Birth. 2014 Sep;41(3):237-44
pubmed: 24720614
Lancet. 2014 Jul 12;384(9938):189-205
pubmed: 24853593
Lancet. 2014 Aug 2;384(9941):455-67
pubmed: 24853599
Lancet. 2014 Aug 2;384(9941):438-54
pubmed: 24853600
Lancet. 2014 Jul 12;384(9938):174-88
pubmed: 24853603
Lancet. 2014 Nov 22;384(9957):1869-1877
pubmed: 25128271
BMC Pediatr. 2014 Sep 16;14:233
pubmed: 25227941
Lancet. 2015 Feb 14;385(9968):629-639
pubmed: 25458726
Bull World Health Organ. 2015 Jan 1;93(1):19-28
pubmed: 25558104
Lancet Glob Health. 2015 May;3(5):e260-70
pubmed: 25866355
BJOG. 2015 Jul;122(8):1045-9
pubmed: 25929823
PLoS One. 2015 May 22;10(5):e0126840
pubmed: 26000829
BJOG. 2016 Feb;123(3):427-36
pubmed: 26259689
BJOG. 2016 Apr;123(5):745-53
pubmed: 26331389
BMC Pregnancy Childbirth. 2015;15 Suppl 2:S5
pubmed: 26391115
BMC Pregnancy Childbirth. 2015;15 Suppl 2:S8
pubmed: 26391444
BJOG. 2016 Apr;123(5):667-70
pubmed: 26681211
Int J Gynaecol Obstet. 2016 Feb;132(2):139-45
pubmed: 26686027
Lancet Glob Health. 2016 Feb;4(2):e98-e108
pubmed: 26795602
Collegian. 2016;23(1):47-52
pubmed: 27188039
Pediatrics. 2016 Jun;137(6):
pubmed: 27225317
J Glob Health. 2016 Jun;6(1):010405
pubmed: 27231541
BMC Pregnancy Childbirth. 2016 Aug 30;16:255
pubmed: 27577266
Med Educ. 2017 Jan;51(1):31-39
pubmed: 27580703
J Glob Health. 2016 Dec;6(2):020502
pubmed: 27606061
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Australas Emerg Nurs J. 2017 Feb;20(1):25-30
pubmed: 28169134
J Glob Health. 2017 Jun;7(1):010801
pubmed: 28607675
Bull World Health Organ. 2017 Oct 1;95(10):683-694
pubmed: 29147041
BMJ. 2018 Jan 24;360:k55
pubmed: 29367432
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
J Glob Health. 2018 Dec;8(2):020804
pubmed: 30202519
Soc Sci Med. 2018 Oct;215:28-35
pubmed: 30205276
J Glob Health. 2019 Jun;9(1):010901
pubmed: 30820319
Stud Fam Plann. 1997 Sep;28(3):203-14
pubmed: 9322336

Auteurs

Louise T Day (LT)

Joint first authors.
Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene &Tropical Medicine (LSHTM), London, UK.

Harriet Ruysen (H)

Joint first authors.
Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene &Tropical Medicine (LSHTM), London, UK.

Vladimir S Gordeev (VS)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene &Tropical Medicine (LSHTM), London, UK.

Georgia R Gore-Langton (GR)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene &Tropical Medicine (LSHTM), London, UK.

Dorothy Boggs (D)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene &Tropical Medicine (LSHTM), London, UK.

Simon Cousens (S)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene &Tropical Medicine (LSHTM), London, UK.

Sarah G Moxon (SG)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene &Tropical Medicine (LSHTM), London, UK.

Hannah Blencowe (H)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene &Tropical Medicine (LSHTM), London, UK.

Angela Baschieri (A)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene &Tropical Medicine (LSHTM), London, UK.

Ahmed Ehsanur Rahman (AE)

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh (iccdr,b), Dhaka, Bangladesh.

Tazeen Tahsina (T)

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh (iccdr,b), Dhaka, Bangladesh.

Sojib Bin Zaman (SB)

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh (iccdr,b), Dhaka, Bangladesh.

Tanvir Hossain (T)

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh (iccdr,b), Dhaka, Bangladesh.

Qazi Sadeq-Ur Rahman (QS)

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh (iccdr,b), Dhaka, Bangladesh.

Shafiqul Ameen (S)

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh (iccdr,b), Dhaka, Bangladesh.

Shams El Arifeen (S)

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh (iccdr,b), Dhaka, Bangladesh.

Ashish Kc (A)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Shree Krishna Shrestha (SK)

Pokhara Academy of Health Science, Pokhara Ranipauwa, Nepal.

Naresh P Kc (NP)

Department of Health Services, Ministry of Health, Kathmandu, Nepal.

Dela Singh (D)

Pokhara Academy of Health Science, Pokhara Ranipauwa, Nepal.

Anjani Kumar Jha (AK)

Nepal Health Research Council, Kathmandu, Nepal.

Bijay Jha (B)

Nepal Health Research Council, Kathmandu, Nepal.

Nisha Rana (N)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Omkar Basnet (O)

Golden Community, Kathmandu, Nepal.

Elisha Joshi (E)

LifeLine Nepal, Kathmandu, Nepal.

Asmita Paudel (A)

Kanti Children's Hospital, Kathmandu, Nepal.

Parashu Ram Shrestha (PR)

Department of Health Services, Ministry of Health, Kathmandu, Nepal.

Deepak Jha (D)

Department of Health Services, Ministry of Health, Kathmandu, Nepal.

Ram Chandra Bastola (RC)

Matri Shishu Miteri Hospital, Pokhara, Nepal.

Jagat Jeevan Ghimire (JJ)

Nepal Health Research Council, Kathmandu, Nepal.

Rajendra Paudel (R)

Kanti Children's Hospital, Kathmandu, Nepal.

Nahya Salim (N)

Department of Paediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.

Donat Shamb (D)

Department of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.

Karim Manji (K)

Department of Paediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.

Josephine Shabani (J)

Department of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.

Kizito Shirima (K)

Department of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.

Namala Mkopi (N)

Department of Paediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.

Mwifadhi Mrisho (M)

Department of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.

Fatuma Manzi (F)

Department of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.

Jennie Jaribu (J)

Department of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.

Edward Kija (E)

Department of Paediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.

Evelyne Assenga (E)

Department of Paediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.

Rodrick Kisenge (R)

Department of Paediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.

Andrea Pembe (A)

Department of Paediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.

Claudia Hanson (C)

Public Health Sciences - Global Health - Health Systems and Policy, Karolinska Institutet, Stockholm, Sweden.

Godfrey Mbaruku (G)

Department of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.
Deceased 2 September 2018.

Honorati Masanja (H)

Department of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.

Agbessi Amouzou (A)

Institute for International Programs, Department of International Health, Johns Hopkins University, Baltimore, Maryland, USA.

Tariq Azim (T)

MEAUSRE Evaluation, University of North Carolina, North Carolina, USA.

Debra Jackson (D)

Knowledge Management & Implementation Research Unit, Health Section, UNICEF, New York, USA.

Theopista John Kabuteni (TJ)

Family and Reproductive Health WHO Tanzania.

Matthews Mathai (M)

Centre for Maternal and Newborn Health, Liverpool School of Tropical Medicine, Liverpool, UK.

Jean-Pierre Monet (JP)

Department for Sexual and Reproductive Health, UNFPA, New York, USA.

Allisyn Moran (A)

Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva, Switzerland.

Pavani Ram (P)

Office of Health, Infectious Disease and Nutrition, Bureau for Global Health, United States Agency for International Development, Washington, DC, USA.

Barbara Rawlins (B)

Jhpiego Baltimore, Baltimore, MD, USA.

Johan Ivar Sæbø (JI)

Department for Informatics, University of Oslo, Oslo, Norway.

Florina Serbanescu (F)

Division of Reproductive Health, Centres for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.

Lara Vaz (L)

Save the Children, Washington, DC, USA.

Nabila Zaka (N)

Knowledge Management & Implementation Research Unit, Health Section, UNICEF, New York, USA.

Joy E Lawn (JE)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene &Tropical Medicine (LSHTM), London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH